✦ LIBER ✦

Multicenter Clinical Trial for Evaluating Methylprednisolone Pulse Treatment of Idiopathic Optic Neuritis in Japan

✍ Scribed by Masato Wakakura; Kimiyo Mashimo; Shinji Oono; Yoshie Matsui; Akio Tabuchi; Kazutaka Kani; Keigo Shikishima; Kazushige Kawai; Yuzo Nakao; Yutaka Tazawa; Motohiro Kiyosawa; Haruki Abe; Norio Ohba; Keiko Yago; Shuji Maeda; Minoru Sugita; Satoshi Ishikawa

Book ID: 114044862
Publisher: Springer
Year: 1999
Tongue: English
Weight: 98 KB
Volume: 43
Category: Article
ISSN: 0021-5155
DOI: 10.1016/s0021-5155(98)00071-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Baseline Features of Idiopathic Optic Ne

Baseline Features of Idiopathic Optic Neuritis as Determined by a Multicenter Treatment Trial in Japan

✍ Masato Wakakura; Risako Minei-Higa; Shinji Oono; Yoshie Matsui; Akio Tabuchi; Ka 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 259 KB

Multicenter clinical trial for evaluatin

Multicenter clinical trial for evaluating the effects of low-frequency pulsing electromagnetic fields (PMFs) in the treatment of congenital and acquired pseudoarthrosis

✍ G. Fontanesi; F. Giancecchi; R. Rotini; I. Tartaglia; A. Dal Monte; G. Poli; E. 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Prospective Randomized Multicenter Trial

Prospective Randomized Multicenter Trial of Sevelamer Hydrochloride and Calcium Carbonate for the Treatment of Hyperphosphatemia in Hemodialysis Patients in Japan

✍ Fumihiko Koiwa; Noritaka Onoda; Hitoshi Kato; Akihide Tokumoto; Tomoyuki Okada; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

S1894 Evaluation of Clinical Symptoms of

S1894 Evaluation of Clinical Symptoms of Gastroesopahgeal Disease with the Questionnaire Is Critical for Treatment with Proton Pump Inhibitor: 146 Patients in Japan Multi Center Trial with the Endoscopic Examination and Questionnaire.

✍ Sakata, Yasuhisa; Fujimoto, Kazuma; Fujiwara, Yasuhiro; Inamori, Masahiko; Tanak 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 143 KB

53 POSTER A phase II, multicenter, rando

53 POSTER A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab (Avastin®) in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride (Tarceva®) compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer

✍ R. Herbst; V. O'Neill; L. Fehrenbacher; C. Belani; P. Bonomi; L. Hart; O. Melnyk 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB